Browse Category

Investment Analysis News 24 October 2025 - 26 October 2025

GM Stock Soars 19% on Surprising Earnings Beat – What’s Driving the Rally?

GM Stock Soars 19% on Surprising Earnings Beat – What’s Driving the Rally?

GM stock surged about 19% in the week ending Oct 24, 2025, closing at roughly $69.66 gmauthority.com, its highest level ever. This jump came after General Motors’ strong third-quarter earnings (EPS of $2.80 vs. $2.31 expected) and upbeat guidance reuters.com news.gm.com. Management raised full-year profit forecasts (now $12.0–13.0 billion EBIT vs. $10.0–12.5B prior) and lowered projected tariff costs to $3.5–4.5 billion reuters.com reuters.com. Analysts have responded positively: TD Cowen raised its 12-month price target to $100 (with a “Buy” rating) marketbeat.com, and others like Wedbush and Citigroup lifted targets to ~$75 marketbeat.com. GM also announced a Q4 dividend and continues large share
Expand Energy (EXE) Stock Soars on LNG & AI Demand — Analysts See 20% Upside

Expand Energy (EXE) Stock Soars on LNG & AI Demand — Analysts See 20% Upside

Key Facts: – Price (Oct 25, 2025): ~$103.8 per share (Nasdaq) reuters.com. – Year-to-date: Up ~4.2% from ~$99.55 on Jan 1 marketbeat.com. – Market Cap: ~$25.5 billion; P/E: ~274; Dividend: $2.30 annually (≈2.2% yield) americanbankingnews.com americanbankingnews.com. – Analyst Consensus: “Strong Buy” (18 analysts); 12-month average price target ~$127.62 (≈22% above recent levels) americanbankingnews.com stockanalysis.com. – Business: Largest independent U.S. natural gas producer (formerly Chesapeake Energy, merged with Southwestern), focused on Appalachian and Haynesville gas fields en.wikipedia.org. – Recent Events: Announced Q3 earnings release (Oct 28) and conference call (Oct 29) quiverquant.com; celebrated first Nasdaq anniversary in early October. Shares of
Ford Stock Rockets on Q3 Earnings Beat – Will the Rally Last Amid EV and Recall Headwinds?

Ford Stock Rockets on Q3 Earnings Beat – Will the Rally Last Amid EV and Recall Headwinds?

Charting the Stock: Support, Resistance and Outlook Technically, analysts note Ford has traded in roughly an $8.60–$13.00 range for the past few years ts2.tech. The stock bounced off the $10–11 area amid October’s turmoil and has found resistance near the prior highs (~$12–$13). A decisive move above ~$13 could signal more upside – one analysis even sees potential toward the mid-teens to $19+ if fundamental trends turn favorable ts2.tech investing.com. On the downside, a break below roughly $10.60 might expose the old $8.60 lows ts2.tech. Recent technical reports highlight Ford’s short-term uptrend (RSI ~65) and a fresh breakout above ~13.20
BigBear.ai Stock Soars 20% on New Defense AI Deal – Is ‘Mini-Palantir’ Rally Here to Stay?

BigBear.ai Stock Soars 20% on New Defense AI Deal – Is ‘Mini-Palantir’ Rally Here to Stay?

Market Performance: A 2025 Rocket Ride BigBear.ai stock has been one of the hottest small-cap tech bets this year. After closing around $6 in late 2024, BBAI has climbed sharply: it surged 22% on Oct. 13 after the Tsecond partnership news (briefly reaching ~$9.39 on Oct. 14) economictimes.indiatimes.com. By Oct. 24 it closed at $7.05 (up 3.98% on the day) stockinvest.us. As of Oct. 25 after-hours trading, the stock was near $7.11 public.com. Overall, 2025 gains are on the order of 80%–100% year-to-date economictimes.indiatimes.com, far outpacing major indexes. Trading volume has spiked with each headline. For example, Oct. 24 saw
IBM Stock Soars on AI, Quantum, and Cloud Hype – Is the Rally Sustainable?

IBM Stock Soars on AI, Quantum, and Cloud Hype – Is the Rally Sustainable?

IBM Stock’s Recent Performance IBM’s stock chart in late 2025 shows a sharp uptrend. After trading in the mid-$200s all summer, shares burst above $280 in mid-October, briefly topping $296 on record volume before pulling back. The Oct. 22 earnings release caused a momentary dip, but by Oct. 24 the stock closed at $307.46 investing.com. This surge puts IBM near the top of its 52-week range (low $203 to high $310 investing.com) and makes it one of the year’s best performers in the Dow Industrials. As one market commentator noted, IBM has become “a quiet way to play AI and
Fluence Energy Stock Skyrockets on Battery Boom – Is the FLNC Rally Here to Stay?

Fluence Energy (FLNC) Stock Skyrockets on $10B Battery Boost and AI Demand – Analysts Sound Warning

Stock Performance & Recent Volatility Fluence’s share price has been on a roller-coaster. After languishing around the mid-$5 range in early September, FLNC surged over 80% to the high teens by mid-October ts2.tech. For example, on Oct 13 the stock jumped ~21% to about $15.89, and on Oct 14 it gained another ~16% to ~$18.45 ts2.tech. In mid-October the shares briefly hit roughly a 52-week high near $24.00 (the past 12-month range is about $3.46–$24.00) marketbeat.com. On Oct 25, Fluence closed at $19.52, up +21.8% on the day reuters.com, continuing a week-long rally. These swings illustrate extreme volatility: FLNC has
Deckers Stock Tanks on Weak Forecast – Is a Rebound Coming?

Deckers (DECK) Stock Slides on Tariff Warning – Can HOKA & UGG Brands Spark a Comeback?

Key Facts: Deckers Brands (NYSE: DECK) closed around $90.50 on Oct. 24, 2025, down ~14% on the day after the company gave softer guidance benzinga.com investopedia.com. In its Oct. 23 earnings release, Deckers reported 2Q FY2026 revenue of $1.43 billion (up 9%) and EPS of $1.82 (up 14%), beating consensus investopedia.com. Management reiterated full-year sales of ~$5.35 billion (down from Street’s ~$5.45B estimate) and EPS guidance of $6.30–$6.39 benzinga.com investopedia.com. Shares tumbled Friday to lead market decliners after CEO Stefano Caroti warned that U.S. consumers may turn “cautious” in the face of rising tariffs and prices investopedia.com investopedia.com. Analysts immediately cut targets:
Booz Allen (BAH) Stock Crashes 9% on Weak Q2; Outlook Cut, Analysts Split on Prospects

Booz Allen (BAH) Stock Crashes 9% on Weak Q2; Outlook Cut, Analysts Split on Prospects

Q2 Results and Stock Reaction Booz Allen’s Oct 24, 2025 earnings release shocked investors. Revenue of $2.89 B missed forecasts and fell 8.1% from last year nasdaq.com, while net profit plunged 55%. Adjusted EPS of $1.49 slightly trailed the $1.51 average estimate nasdaq.com. Management blamed a “bifurcated” market – national security projects are healthy, but civil and commercial work is lagging investing.com. In response, the company sharply cut its full-year outlook (FY2026 revenue now ~$11.4 B vs. previously ~$12.3 B) investing.com. Shares fell about 9.4% on the news. In pre-market trading Oct 24 they hit ~$89.75, near the 52-week low investing.com. By market
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Cloud and AI Drive Momentum Microsoft’s Azure cloud has been the standout. In FY2025 Azure revenue surpassed $75B, growing ~34% ts2.tech ts2.tech. Analysts note Azure continues to accelerate: in Q4 it was up ~39%, handily beating AWS and Google Cloud ts2.tech. That dominance is a key reason for the stock’s rally. As TechStock² (TS2.Tech) reports, Wall Street “still sees $600–$650 [over 12 months]” for MSFT ts2.tech. Indeed, banks like UBS and Bank of America recently reiterated Buy ratings and raised targets to ~$650 and $640, respectively insidermonkey.com ts2.tech. UBS “highlighted accelerating Azure growth trends” in its $650 target insidermonkey.com, and
Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta’s Oct. 24 announcement ignited optimism. According to the official press release, Anemocyte will incorporate Genenta’s clinically validated LVV plasmid DNA platform (originating from Naldini’s research) into its production pipeline investing.com. “By making our clinically validated LVV plasmid DNA technology platform available to Anemocyte and its clients, we are contributing to the reliable and scalable development of advanced therapy programs across the industry,” said CEO Pierluigi Paracchi investing.com. Anemocyte’s CEO Marco Ferrari added that the deal ensures customers have access to “a robust, well-established platform” for cutting-edge cell therapies investing.com. In effect, the partnership helps Genenta and its clients secure
IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

Stock Performance and Price In late October 2025, IonQ’s share price was around $60 after a tumultuous run. The stock peaked near $82 on Oct. 13 – a 75% year-to-date gain – but then fell back into the $60s ts2.tech ts2.tech. By Oct. 23 (the last full trading day), IonQ closed near $59.4 marketbeat.com. That week, Wednesday’s WSJ news and Thursday’s session saw large intraday swings: the price spiked to about $62.9 mid-day on Oct. 23 before settling around $59–60 marketbeat.com. Trading volume has been very heavy. For example, on Oct. 23 roughly 65 million shares traded hands – nearly triple the typical daily
AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T Stock Seesaws on Subscriber Surge – Will T’s Telecom Gambit Pay Off?

AT&T Stock Price: Latest Moves and Trends AT&T’s stock is hovering in the mid-$24s as of October 24, 2025, after a choppy week. Shares closed at $24.62 on Thursday nasdaq.com, down from around $26.10 on Monday investing.com. That slide of roughly 5.7% erased gains from earlier in the month. The volatility came amid earnings results and broader market swings – AT&T had been mostly range-bound in the mid-$20s throughout October ts2.tech before this week’s drop. Even so, the stock remains about 20% higher than a year ago ts2.tech, reflecting a recovery from 2024 levels. Over the past 12 months AT&T
1 18 19 20 21 22 31
Go toTop